Bullous pemphigoid

Toggle: English / Spanish

Definition

Bullous pemphigoid is a skin disorder characterized by large blisters.

Alternative Names

Causes, incidence, and risk factors

The cause is not known, but may be related to immune system disorders, certain other diseases, or use of some medications.

Bullous pemphigoid usually occurs in elderly persons and is rare in young people. Symptoms come and go. In most patients, the condition goes away within 5 years.

Symptoms

Some people have no symptoms. Others may have mild redness, itching and irritation.

In severe cases, they are multiple blisters, called

. Blisters are usually located on the arms, legs, or middle of the body. About one-third of persons with bullous pemphigoid also develop blisters in the mouth. The blisters may break open and form or open sores.

Other symptoms may include:

Signs and tests

Tests that may be done to help diagnose this condition include:

Treatment

Powerful anti-inflammatory medicines called corticosteroids may be prescribed. Some corticosteroids are taken by mouth, while others require a shot (injection). In persons with early forms of the disease, corticosteroid creams may be used.

Your doctor may prescribe chemotherapy or medicines to help suppress the immune system.

Antibiotics in the tetracycline family may be useful in mild cases. Niacin (a B complex vitamin) is sometimes given along with tetracycline.

Support Groups

Expectations (prognosis)

Bullous pemphigoid usually responds well to treatment. Most patients stop taking medicine after several years. The disease sometimes returns after treatment is stopped.

Complications

Skin infection is the most common complication.

Calling your health care provider

Call your doctor for an appointment if you have:

  • Unexplained blisters on your skin
  • An itchy rash that continues despite home treatment

Prevention

References

Bernard P, Borradori L. Pemphigoid group. In: Bolognia JL, Jorizzo JL, Schaffer JV, eds. Dermatology. 3rd ed. Philadelphia, Pa.: Elsevier Saunders; 2012:chap 30.

Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Philadelphia, Pa.: Elsevier Mosby; 2009:chap 16.

Version Info

  • Last reviewed on 5/15/2013
  • Kevin Berman, MD, PhD, Atlanta Center for Dermatologic Disease, Atlanta, GA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch)

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2013 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

This page was last updated: May 20, 2014

         
Average rating (31)